Sethera Therapeutics’ Polymacrocyclic Peptide Platform Selected for CDMRP-Supported Mutant p53 Breast Cancer Program
The work, led by Roswell Park’s Katerina Gurova, PhD, and [...]
Lifespan Vision Ventures Leads Remedium Bio’s Series A Financing LifeSpan Vision Ventures
Investment supports advancement of Remedium’s durable protein therapeutics platform toward [...]
Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch
New investor Horizon 3 Healthcare led the round, which was [...]
Endo Tools Therapeutics Secures $23 million in Series C Financing to Advance The endomina® technology and Commercialization of New endomina EZFuse System
Funding to accelerate U.S., European and Middle East commercialization and [...]
Celerion Expands Zurich Bioanalytical Laboratory to Meet Growing Market Demand
The investment strengthens Celerion’s ability to support increasing global demand [...]
Auxilium and MBI Announce First Accelerator Cohort, Investing $1 Million Across Four Life Science and Healthcare Startups
Through the program, Auxilium will invest a total of $1 [...]
Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development
Ingenix’s Biological Reasoning Engine fuses biological data through Modality Fusion, [...]
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
Financing supports the approval of U.S. Investigational Device Exemption (IDE), [...]
Secretome Therapeutics Announces $30 Million Series A Financing
From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy [...]
Ember LifeSciences reports new strategic investments boosting Series A to $27M
The investments follow after they previously announced Series A financing [...]